The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia

Despite the development of therapeutic agents that selectively target cancer cells, relapse driven by acquired drug resistance and resulting treatment failure remains a significant issue. The highly conserved Hedgehog (HH) signaling pathway performs multiple roles in both development and tissue home...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Andrew, Turner, Kelly A., Woolfson, Adrian, Jiang, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053130/
https://www.ncbi.nlm.nih.gov/pubmed/36986819
http://dx.doi.org/10.3390/pharmaceutics15030958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053130/
https://www.ncbi.nlm.nih.gov/pubmed/36986819
http://dx.doi.org/10.3390/pharmaceutics15030958

Ejemplares similares